Chlorambucil is a type of medicine used to treat certain types of cancer, like leukemia. It works by stopping cancer cells from growing. It's a strong medicine and is known to cause cancer itself, so it's used carefully only when the benefits outweigh the risks.
Every report comes from a Lived member, sent anonymously.
Have you tried Leukeran (Chlorambucil) for CLL (Chronic Lymphocytic Leukemia)?
Chlorambucil, sold in the US as Leukeran, is a chemotherapy tablet used to treat chronic lymphocytic leukemia (CLL), a slow-growing cancer of white blood cells, and certain lymphomas, including follicular lymphoma and Hodgkin lymphoma. It can also be combined with obinutuzumab (Gazyva), an antibody drug given by infusion, for people starting their first treatment for CLL. Chlorambucil can shrink the disease and ease its effects, but it does not cure CLL or lymphoma. Its role has narrowed in recent years. In large trials of people starting CLL treatment, newer targeted regimens, such as venetoclax plus obinutuzumab or acalabrutinib, a targeted pill that blocks a signaling protein called Bruton tyrosine kinase, kept the disease under control for longer than chlorambucil plus obinutuzumab. Chlorambucil remains an approved option, and a doctor may weigh it against these newer treatments based on a person's overall health and circumstances.
Chlorambucil belongs to a group of chemotherapy drugs called alkylating agents. It attaches to DNA inside cells and damages it, which stops cells from copying their DNA and dividing. Cells that cannot repair this damage are triggered to die. Cancerous white blood cells divide and build up, so they are especially affected. Healthy cells that divide often, particularly the blood-forming cells in the bone marrow, are affected too. That is why lower blood counts are the main side effect, and why the same DNA damage can, years later, raise the risk of a new cancer.
Chlorambucil comes as a small 2 mg tablet taken by mouth. It is not given as an injection. A common pattern is one daily dose for a few weeks at a time; other schedules use a single larger dose every two weeks or once a month, or pair the tablets with obinutuzumab infusions in set cycles. The dose is based on body weight, the type of cancer and blood counts, and is often lowered or paused when counts drop. Blood tests are central to treatment. The care team usually checks a complete blood count every week while a person is taking chlorambucil, because the marrow can be harmed seriously if counts fall unnoticed. Food lowers how much of the drug is absorbed, so ask how to time doses around meals. The tablets are stored in the refrigerator, and because chlorambucil is a cancer drug, ask the pharmacist how household members should handle and dispose of it. If a dose is missed, follow the care team's instructions rather than doubling up.
The most important side effect is lower blood counts, which the drug's boxed warning (the most prominent warning the US Food and Drug Administration requires) highlights as potentially severe bone marrow suppression. Low white cells raise the risk of infection, low platelets cause easier bruising or bleeding, and low red cells (anemia) can cause tiredness. These effects are usually reversible when the dose is reduced or stopped early, and counts can keep falling for about 10 days after the last tablet. Nausea, vomiting, diarrhea and mouth sores can happen but are less common than with many chemotherapy drugs. Contact the care team right away for a fever, sore throat or other signs of infection; unusual bruising or bleeding, black stools or red urine; any skin rash, which can rarely progress to a severe blistering reaction; yellowing of the skin or eyes or dark urine; a persistent cough or trouble breathing; or a seizure. Seizures, liver injury and lung scarring are rare. Missed periods are also worth reporting.
Chlorambucil's boxed warning covers three long-term risks beyond low blood counts. It can cause new cancers, especially acute leukemia, and this risk rises with longer treatment and higher total doses, which is one reason short courses are generally preferred over continuous treatment. It can cause infertility in both men and women, sometimes permanently. And it can harm a developing baby, so people who could become pregnant should use reliable birth control and tell the care team promptly if pregnancy occurs. Because of possible harm to a nursing infant, breastfeeding and treatment usually are not combined; this is a decision to make with the care team. No specific drug interactions are listed on the label, but timing with other cancer treatment matters: full doses are usually avoided within four weeks of a full course of radiation or other chemotherapy, because the bone marrow is more easily damaged then. Live vaccines should be avoided while the immune system is weakened. Tell the prescriber about any history of seizures or head injury, medicines that can lower the seizure threshold, liver disease, or a past allergic reaction to chlorambucil or a related drug such as bendamustine. Chlorambucil is not used if the cancer has previously stopped responding to it.
Chlorambucil works gradually. Blood counts and enlarged lymph nodes or spleen are tracked over weeks to judge whether the disease is responding, and the dose is adjusted along the way. Because CLL often grows slowly, not everyone with the diagnosis needs treatment right away; in early-stage CLL, starting chlorambucil immediately did not help people live longer than waiting until treatment was needed. Treatment typically runs in defined courses rather than indefinitely. Once the disease is under good control, doctors often stop the drug and restart it if the cancer returns, which limits the total dose and the long-term risks. Regular blood tests continue throughout, and follow-up after treatment watches for relapse and for later effects such as low counts or new cancers.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Leukeran (Chlorambucil), what you've noticed, or ask the community a question.